Results 41 to 50 of about 97 (93)

Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab. [PDF]

NPJ Precis Oncol
Gogas H, Ravimohan S, Datta A, Chhibber A, Couselo EM, Diab A, Pereira C, Quéreux G, Sandhu S, Curti B, Khushalani NI, Taylor MH, Daniels GA, Spreafico A, Meniawy T, Van Den Eertwegh AJM, Sun Y, Arriaga Y, Zhou M, Long GV, Lebbé C.   +20 more
europepmc   +1 more source

Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC). [PDF]

Ann Oncol
Fernandez-Martinez A, Tanioka M, Ahn SG, Zagami P, Pascual T, Rediti M, Tang G, Hoadley KA, Venet D, Rashid NU, Spears PA, Di Cosimo S, de Azambuja E, Choudhury A, Rastogi P, Islam MN, Cortes J, Llombart-Cussac A, Swain SM, Sotiriou C, Prat A, Perou CM, Carey LA.   +22 more
europepmc   +1 more source

Beluga whale summer habitat associations in the Nelson River estuary, western Hudson Bay, Canada. [PDF]

PLoS One, 2017
Smith AJ, Higdon JW, Richard P, Orr J, Bernhardt W, Ferguson SH.   +5 more
europepmc   +1 more source

Uncovering the Core Microbiome and Distribution of Palmerolide in <i>Synoicum adareanum</i> Across the Anvers Island Archipelago<i>,</i> Antarctica. [PDF]

Mar Drugs, 2020
Murray AE, Avalon NE, Bishop L, Davenport KW, Delage E, Dichosa AEK, Eveillard D, Higham ML, Kokkaliari S, Lo CC, Riesenfeld CS, Young RM, Chain PSG, Baker BJ.   +13 more
europepmc   +1 more source

Immune Monitoring after Cell Therapy and Hematopoietic Cell Transplantation: Guidelines by the ISCT Stem Cell Engineering Committee. [PDF]

Cytotherapy
Oppizzi L, Hosszu K, Prockop S, Bidgoli A, Bonfim C, Ciccocioppo R, Ruggeri A, Maiers M, Bertaina A, Boelens JJ.   +9 more
europepmc   +1 more source

Development of CAR-T cell therapy for B-ALL using a point-of-care approach. [PDF]

Oncoimmunology, 2020
de Macedo Abdo L, Barros LRC, Saldanha Viegas M, Vieira Codeço Marques L, de Sousa Ferreira P, Chicaybam L, Bonamino MH.   +6 more
europepmc   +1 more source

Endothelin-1 signaling in the kidney: recent advances and remaining gaps. [PDF]

Am J Physiol Renal Physiol
Brooks AJ, Gallego-López MDC, De Miguel C.   +2 more
europepmc   +1 more source

The butterfly rash of lupus: an example of aposematism? [PDF]

Arthritis Res Ther, 2013
Pisetsky DS.
europepmc   +1 more source

Outcomes of subsequent antilymphoma therapies after second-line axicabtagene ciloleucel or standard of care in ZUMA-7. [PDF]

Blood Adv
Ghobadi A, Munoz J, Westin JR, Locke FL, Miklos DB, Rapoport AP, Perales MA, Reagan PM, McGuirk J, Jacobson CA, Kersten MJ, Avivi I, Peng A, Schupp M, To C, Oluwole OO.   +15 more
europepmc   +1 more source

Changes in IDH2, TET2 and KDM2B Gene Expression After Treatment With Classic Chemotherapeutic Agents and Decitabine in Myelogenous Leukemia Cell Lines. [PDF]

J Hematol, 2019
Alves J, Dexheimer GM, Reckzigel L, Goettert M, Biolchi V, Abujamra AL.   +5 more
europepmc   +1 more source